(Q71171386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

16 October 2019

main subject

0 references

4

P Invernizzi

1 reference

16 October 2019

A Crosignani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

P M Battezzati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

K D Setchell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

G Covini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M Zuin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M Podda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 April 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

809-815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02213140

16 October 2019

exact match

0 references

cites work

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

12 December 2020

Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid

1 reference

12 December 2020

Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions

1 reference

12 December 2020

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

1 reference

12 December 2020

Enterohepatic circulation in man. A simple method for the determination of duodenal bile acids.

1 reference

12 December 2020

Hepatic transport of bile acids in the isolated perfused rat liver. Structure-kinetic relationship

1 reference

12 December 2020

Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.

1 reference

12 December 2020

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

1 reference

12 December 2020

Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration

1 reference

12 December 2020

Chemistry and enterohepatic circulation of bile acids

1 reference

12 December 2020

Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver

1 reference

12 December 2020

Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

12 December 2020

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate

1 reference

12 December 2020

Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

1 reference

12 December 2020

Structure-activity relationship studies on natural and synthetic bile acid analogs.

1 reference

12 December 2020

High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids

1 reference

12 December 2020

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem

1 reference

12 December 2020

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

1 reference

12 December 2020

Effect of different doses of ursodeoxycholic acid in chronic liver disease

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Absorption of urso- and chenodeoxycholic acid and their taurine and glycine conjugates in rat jejunum, ileum, and colon.

1 reference

12 December 2020

Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.

1 reference

12 December 2020

A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Intestinal absorption of ursodeoxycholic, glycoursodeoxycholic and tauroursodeoxycholic acids in rats

1 reference

12 December 2020

The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC

1 reference

12 December 2020

Uptake of bile acids by perfused rat liver: evidence of a structure-activity relationship

1 reference

12 December 2020

Chromatographic methods for bile acid analysis

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

1 reference

12 December 2020

A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges

1 reference

12 December 2020

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02213140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674405%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference